Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

NEUROGENIC MODULATION BY NEUROKININ-1 RECEPTOR ANTAGONIST, CP-96,345 TO INHIBIT RHEUMATOID ARTHRITIS DEVELOPMENT IN ADJUVANT INDUCED ARTHRITIS RAT MODEL

Folia Medica Indonesiana · Vol. 52 No. 2 (2017) · hlm. 87–87

DOI
10.20473/fmi.v52i2.5216
ISSN
2355-8393, 2599-056X
Terbit
2017-08-08
Penerbit
Airlangga University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0/

Abstrak

Rheumatoid arthritis (RA) is a chronic form of persistent inflammation. Meanwhile, Substance P is the most associated neuropeptide in neurogenic inflammation and hyperalgesia commonly found in chronic pain. Substance P act by binding to neurokinin-1 receptor. The present study was conducted to evaluate the effect of neurokinin-1 receptor antagonist (CP-96,345) on Adjuvant Induced Arthritis rat model, induced by Complete Freund’s Adjuvant (CFA). The objective is to attenuate neurogenic inflammation which in turn will increase the latency time of hyperalgesia response, decreases neurokinin-1 receptor expression, and inhibits the development of RA in AIA rat model. Rats were intra-articularly injected with CFA 1 hour after the administration of CP-96,345 either by 0.63 µg/gr; 1.25 µg/gr; or 2.5 µg/gr also intra-articularly. Caliper measurements and hot-plate test were performed on day 0, 3, 5, 7, 9, 11, and day 13. Expression of neurokinin-1 receptor in joint tissue were evaluated by immunohistochemistry, and RA progress in joint tissue were observed hystopathologically. CP-96,345 at 2.5 µg/gr significantly increases the latency of hyperalgesia response time on CFA induced rats (p=0.044) and decreased the neurokinin-1 receptor expression in joint tissue (p=0.029) compared to CFA induced rats. There was no significant difference for caliper measurements and RA progress between CFA incduced rats and treated group. Conclusively, CP-96,345 increases the latency of hyperalgesia response time and decreases the NK-1 receptor expression in rat joint but could not inhibit RA progression.

Kata kunci

Jaringan kolaborasi para penulis

26 penulis · 57 tautan kepenulisan bersama · 15 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Politeknik Baubau
  • Lambung Mangkurat University
  • Tadulako University
  • University of Brawijaya
  • Joseph Sarwuan Tarka University Makurdi
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Budi SupraptiUniversitas Airlangga4
Eddy RahardjoUniversitas Airlangga4
Dewi Wara ShintaUniversitas Airlangga4
Selvi MegawatiUniversitas Airlangga3
Ika Ayu MentariUniversitas Airlangga2
Rifda NaufalinaUniversitas Airlangga2
Dewi Perwito SariUniversitas Airlangga2
Sarah Puspita AtmajaUniversitas Airlangga2
Rifda Naufa LinaUniversitas Airlangga2
Wa Ode SyafriahPoliteknik Baubau1
Hasty HamzahPoliteknik Baubau1
Suharjono SuharjonoUniversity of Brawijaya1
Muhammad Darwin PrenggonoLambung Mangkurat University1
Ratih Pratiwi SariUniversitas Airlangga1
Aditya Maulana Perdana PutraLambung Mangkurat University1
Endang Dewi MasithahUniversitas Airlangga1
Aondohemba Samuel NegeJoseph Sarwuan Tarka University Makurdi1
Cantika Suci Adlina LasandaraUniversitas Airlangga1
Samirah SamirahUniversitas Airlangga1
Aniek Setiya BudiatinUniversitas Airlangga1
Nila KurniasariUniversitas Airlangga1
Imelda TheodoraUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">NEUROGENIC MODULATION BY NEUROKININ-1 RECEPTOR ANTAGONIST, CP-96,345 TO INHIBIT RHEUMATOID ARTHRITIS DEVELOPMENT IN ADJUVANT INDUCED ARTHRITIS RAT MODEL</dc:title><dc:creator>Yuyun Wirasasmita</dc:creator><dc:creator>Mahardian Rahmadi</dc:creator><dc:creator>Imam Susilo</dc:creator><dc:creator>Junaidi Khotib</dc:creator><dc:subject>rheumatoid arthritis</dc:subject><dc:subject>NK1 receptor antagonists</dc:subject><dc:subject>CP-96,345</dc:subject><dc:subject>substance P</dc:subject><dc:subject>adjuvant-induced arthritis</dc:subject><dc:subject>neurogenic inflammation</dc:subject><dc:subject>hyperalgesia</dc:subject><dc:subject>joint inflammation</dc:subject><dc:subject>chronic pain</dc:subject><dc:description xml:lang="en">Rheumatoid arthritis (RA) is a chronic form of persistent inflammation. Meanwhile, Substance P is the most associated neuropeptide in neurogenic inflammation and hyperalgesia commonly found in chronic pain. Substance P act by binding to neurokinin-1 receptor. The present study was conducted to evaluate the effect of neurokinin-1 receptor antagonist (CP-96,345) on Adjuvant Induced Arthritis rat model, induced by Complete Freund’s Adjuvant (CFA). The objective is to attenuate neurogenic inflammation which in turn will increase the latency time of hyperalgesia response, decreases neurokinin-1 receptor expression, and inhibits the development of RA in AIA rat model. Rats were intra-articularly injected with CFA 1 hour after the administration of CP-96,345 either by 0.63 µg/gr; 1.25 µg/gr; or 2.5 µg/gr also intra-articularly. Caliper measurements and hot-plate test were performed on day 0, 3, 5, 7, 9, 11, and day 13. Expression of neurokinin-1 receptor in joint tissue were evaluated by immunohistochemistry, and RA progress in joint tissue were observed hystopathologically. CP-96,345 at 2.5 µg/gr significantly increases the latency of hyperalgesia response time on CFA induced rats (p=0.044) and decreased the neurokinin-1 receptor expression in joint tissue (p=0.029) compared to CFA induced rats. There was no significant difference for caliper measurements and RA progress between CFA incduced rats and treated group. Conclusively, CP-96,345 increases the latency of hyperalgesia response time and decreases the NK-1 receptor expression in rat joint but could not inhibit RA progression.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2017-08-08</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v52i2.5216</dc:identifier><dc:identifier>10.20473/fmi.v52i2.5216</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 52 No 2 (2017); 87-87</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/5216/3326</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>